Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma

HG146 is available as Capsule at a unit dose strength of 5 mg and 10 mg.

PD-(L)1 Antibody is available as solution for infusion or lyophilized powder for reconstitution to be administered Q3W. It will be administered as an IV infusion for 30 minutes.